share_log

DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $94

DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $94

DA Davidson对Medifast保持中立,将目标价下调至94美元
Benzinga Real-time News ·  2023/02/22 04:41

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $106 to $94.

Da Davidson分析师Linda Bolton Weiser维持Medifast(纽约证券交易所代码:MED)中性,并将目标价从106美元下调至94美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发